Spatial Transcriptomics Capture Probes for Reliable Tissue Mapping

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods fail to provide spatially resolved data on analyte distribution within tissues due to variations in permeabilization conditions affecting downstream capture and sequencing, and lack sensitivity and specificity in analyte detection.

Innovation Solution

A method involving capture probes with a capture domain at the 3′ end, template switching oligonucleotides, and fluorophore-quencher pairs for enhanced analyte detection, allowing for spatial analysis of RNA or DNA in biological samples.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional spatial analysis methods are used, then tissue structure can be visualized, but spatially resolved analyte distribution data cannot be obtained due to permeabilization condition variations

Engineering Contradiction:
Improvespatial resolution of analyte detectionVSAvoidconsistency of downstream capture and sequencing
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent introduces capture probes as intermediary molecules that bridge the analyte (RNA/DNA) and the detection system. These probes contain capture domains that specifically bind to target analytes and spatial barcodes that encode position information. The capture probes are designed with controlled permeabilization conditions that work across different tissue types, serving as a universal mediator that decouples the tissue-specific permeabilization challenge from the downstream detection reliability.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent systematically varies permeabilization parameters (enzyme type, concentration, temperature, time) to optimize analyte release while maintaining capture probe functionality. By establishing standardized permeabilization protocols and adjusting key parameters based on tissue type, the method achieves consistent analyte release that enables reliable downstream capture and sequencing across different biological samples.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If permeabilization conditions are optimized for one tissue type, then analyte release is improved, but performance on other tissue types deteriorates

Engineering Contradiction:
Improveanalyte release efficiencyVSAvoidapplicability across different biological samples
Core Design Contradiction:
ProductivityVSAdaptability or versatility

Solution Approach 1:

The capture probes are designed with universal functionality that works across multiple tissue types. The probe structure includes a standardized capture domain, spatial barcode, and adapter sequence that remain consistent regardless of tissue type. This universality is achieved by decoupling the tissue-specific permeabilization step from the tissue-independent capture and detection steps, allowing the same probe design to be applied broadly while only adjusting permeabilization conditions.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The method segments the spatial transcriptomics workflow into distinct modules: (1) tissue-specific permeabilization to release analytes, (2) universal capture probe binding to captured analytes, and (3) standardized downstream processing. This segmentation allows optimization of each module independently, with permeabilization conditions tailored to specific tissue types while maintaining consistent capture and detection protocols across all samples.

Inventive Principle:
Principle #1Segmentation

3Measurement precision

If sensitivity of analyte detection is increased, then rare transcripts can be detected, but background noise and false positives increase

Engineering Contradiction:
Improvedetection sensitivityVSAvoidspecificity of analyte detection
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The capture probe acts as a specific intermediary that mediates between the analyte and detection system. The capture domain is designed to specifically bind to the target analyte sequence, while the spatial barcode and adapter sequences provide additional layers of specificity. This multi-component intermediary structure enables sensitive detection of rare transcripts while maintaining high specificity by requiring multiple specific interactions rather than a single weak interaction.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The method performs preliminary capture and enrichment of target analytes before final detection. Capture probes are introduced early in the workflow to specifically bind and concentrate target transcripts from complex tissue samples. This preliminary enrichment step increases the relative abundance of target analytes, enabling sensitive detection while the specific capture probe-analyte binding ensures high fidelity and reduces background noise from non-specific sources.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Improves the sensitivity and specificity of analyte capture and detection, enabling spatially resolved analysis of RNA or DNA in tissues by utilizing fluorophore-quencher pairs and template switching oligonucleotides.

Implementation Method 1

measuring presence or absence of fluorescence upon release of the first oligonucleotide from the second oligonucleotide

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Implementation Method 2

a target analyte released from the biological sample is specifically bound by the capture domain of the capture probe

Methodology Applied
Scientific EffectSpecific binding: Adsorption

Implementation Method 3

the first homopolynucleotide sequence hybridizes to the second homopolynucleotide sequence

Methodology Applied
Scientific EffectHybridization:

Implementation Method 4

generating a second strand that comprises in a 5′ to a 3′ direction

Methodology Applied
Scientific EffectPCR amplification:

Data Source

PatentUS20260049349A1Materials and methods for spatial transcriptomics
Publication Date: 2026.02.19 10X GENOMICS INC
  • US20260049349A1 patent drawing
  • US20260049349A1 patent drawing
  • US20260049349A1 patent drawing

AI summary

Provided herein are methods of determining efficiencies of spatial transcriptomics methods.